Calculate MELD and MELD-Na scores for liver disease severity assessment. Enter lab values to determine transplant priority and 3-month mortality risk.
MELD (Model for End-Stage Liver Disease) is used to prioritize patients for liver transplantation. Higher scores indicate greater disease severity and higher priority on the transplant waiting list.
MELD-Na incorporates serum sodium, which improves prediction of mortality in patients with cirrhosis. Low sodium levels (hyponatremia) are associated with worse outcomes. MELD-Na is now the standard for transplant allocation in many countries.
The 3-month mortality estimates are population averages. Individual outcomes vary based on the specific liver disease, complications, treatment, and overall health status.